Pending Mobile Medical Apps Guidance Provokes Heated Controversy
This article was originally published in The Gray Sheet
Executive Summary
An impassioned debate brewing about FDA’s planned timing for finalizing mobile medical apps guidance bubbled to the surface at a recent meeting of the HHS workgroup tasked with recommending a health IT regulatory framework. Despite pressure to delay the guidance, FDA says it is still pushing ahead.